MMedication Read More Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up studyFebruary 12, 2026 This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
BBusiness Read More Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in LondonOctober 30, 2025 SAN FRANCISCO, Oct. 30, 2025 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be webcasting its…
HHealthcare Read More These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing?September 27, 2025 Shares of Nektar Therapeutics and Mineralys Therapeutics have risen sharply, and could run even further. Nektar is developing…